Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium ...
Efficacy and safety of the muscarinic receptor agonist KarXT ...
KarXT Receives Positive Top-Line Data in Phase III EMERGENT-2 Trial for ...
Karuna Therapeutics: KarXT Could Become A New Standard Of Care In ...
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium): Post Hoc ...
Karxt efficacy compared to current drugs - Medications - Schizophrenia.com
Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2 ...
FDA Approves the Oral Medication KarXT for Schizophrenia
Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study
KarXT Shows Remarkable Reductions in Schizophrenia Symptoms
(PDF) Effectiveness of KarXT (xanomeline-trospium) for cognitive ...
Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment ...
KarXT for Schizophrenia: Mechanism of Action? - YouTube
FDA accepts KarXT new drug application for treating schizophrenia
KarXT Effective in Improving Schizophrenia Symptoms at 52 Weeks
KarXT for Schizophrenia: No anti-psychotics anymore? - MEDizzy Journal
Karuna Therapeutics Advances Alzheimer’s Psychosis Treatment with KarXT ...
(PDF) Safety and tolerability of KarXT (xanomeline–trospium) in a phase ...
EMERGENT Trial Data For KarXT Shows Promise in Schizophrenia
Zai Lab's Q4 2024: Contradictions in VYVGART Growth, KarXT Strategy ...
Karuna’s KarXT is Evaluate's most anticipated drug for 2024 | Seeking Alpha
Post Hoc Analysis Explores Risk-Benefit Profile of KarXT
Study of KarXT (trospium chloride and xanomeline tartrate) in patients ...
KarXT for Alzheimer's-Associated Psychosis Clinical Trial 2025 | Power
The Latest Updates on KarXT
FDA approves PureTech’s KarXT to treat schizophrenia in adults
Study on KarXT (Trospium Chloride, Xanomeline Tartrate) for Treating ...
Five Advantages of Taking KarXT (Cobenfy)/ A Summary Article for ...
Karxt (A New Mechanism Antipsychotic Based on Xanomeline), Is Superior ...
Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline ...
Will Bristol Myers’ patent gamble for Karuna’s KarXT pay off? — Markman ...
KarXT Phase 3 Efficacy and Safety in Schizophrenia
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement ...
This month, the FDA could approve KarXT — an oral dual M1/M4 muscarinic ...
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC ...
KarXT for Schizophrenia: Mechanism of Action? | Vumedi
How Karuna's schizophrenia med KarXT went from a 'serendipitous ...
Karxt PANSS out again for Karuna; NDA slated for midyear - News ...
PureTech's Karuna Receives Positive Results From Its KarXT Blood ...
A Study to Assess Efficacy and Safety of KarXT for the Treatment of ...
Safety and tolerability of KarXT (xanomeline-trospium) in a phase 2 ...
Anticipation Grows for BMS’ KarXT as Schizophrenia Space Awaits ...
PureTech-Invented KarXT Receives U.S. Food and Drug Administration ...
Karuna’s Robust Liquidity Paves Way For KarXT Milestones (Rating ...
Karuna Therapeutics’ NDA for KarXT accepted by USFDA - Express Pharma
精神分裂症重磅品种： KarXT 在III 期 EMERGENT-2 试验中获得积极顶线数据，再鼎预付3500万美元拥有国内权益|精神分裂症 ...
Ahead of its upcoming decision date, a competitor takes aim at KarXT ...
KarXT shows remarkable safety and efficacy in schizophrenia patients ...
KarXT demonstrates effectiveness against the negative symptoms of ...
精神分裂症，下一个重磅药物诞生之地_财富号_东方财富网
KarXT: A New Medication For Treating Schizophrenia - Michael Halassa ...
The US FDA has approved Cobenfy, also known as KarXT, a new ...
再鼎医药公布KarXT精神分裂症中国3期桥接研究数据——药研快讯
Slide 19
Programs — Karuna Therapeutics
Slide 18
Matsblog Japan
Slide 17
Slide 15
KarXT: an innovative and promising treatment for schizophrenia
Slide 14
FDA weighs KarXT, first schizophrenia drug shift in decades
Cobenfy: Breakthrough New Drug for Schizophrenia Treatment | BioPharma.News
Karuna's KarXT: Limited Distinction In Schizophrenia, Yet Warrants ...
KarXT: an innovative and promising treatment for schizophrenia | The ...
KarXT: A New Progress in The Battle Against Schizophrenia
Karuna Therapeutics: Rewiring The Schizophrenia Paradigm Leap Beyond ...
Facebook Live 003: New Treatments in Pipeline – Psychiatry Education Forum
原研未批首仿先行！恩华药业国内首仿精神分裂症新药KarXT，或抢占200亿市场！_摩熵医药(原药融云)
KarXT: A New Hope for Schizophrenia Patients, Phase III Trial Data ...
Slide 9
Our overarching goal is to achieve sustainable, top-quartile growth ...
FDA批准COBENFY(KarXT)用于精神分裂症治疗 | 香港致泰药业
Understanding KarXT: A Novel Drug for Schizophrenia Treatment
重磅！70年来首个新机制精神分裂症新药KarXT在中国上市 - 哔哩哔哩
KarXT最新消息丨BMS创新机制精神分裂症药物，或将打破半世纪僵局_摩熵医药
Xanomeline–Trospium (KarXT): Mechanism and Clinical Role in Schizophrenia
精神分裂症疗法3期临床达主要终点，再鼎医药拥有大中华区权益 3月20日，Karuna Therapeutics公司宣布，其在研产品KarXT ...
Video List | CARLAT PUBLISHING
Why approval of KarXT, the first new drug for schizophrenia in decades ...
Slide 7
【フェーズ3試験/EMERGENT-3】「KarXT」オランザピンに勝る有効性を示す(3回目) - メンタル系最新情報ブログ～新薬＆最新研究など～
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily ...
2030年日本発売か!?「KarXT(コベンフィ)」の長期有効性は高い/長期投与試験結果/EMERGENT-4 - メンタル系最新情報ブログ ...
Our Pipeline – Seaport Therapeutics
全球首批！创新机制疗法获FDA批准，再鼎医药这款新药的潜力有多大？医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
KARXT: A BREAKTHROUGH SCHIZOPHRENIA MEDICATION | Mya Care
Karuna：精神分裂症新药KarXT三期临床公布！再鼎医药引入_摩熵医药(原药融云)
FDA Approves Cobenfy, Previously KarXT, for Treatment of Schizophrenia
KarXT: PDUFA Date Approaches for Potential Treatment for Schizophrenia
Antipsychotic Demonstrates Efficacy - CenExel
Bristol Myers Squibb Reveals Promising Data for KarXT, a Potential ...
02190-6/asset/33d8937e-8176-4704-a111-508d6120034b/main.assets/gr1_lrg.jpg)
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg)
)
